Trial Profile
A Randomized, Double-Blind, Placebo Controlled Study to Assess Safety and Tolerability of RotaVac Vaccine (Live Attenuated Bovine-Human (UK) Reassortant Pentavalent Rotavirus Vaccine).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Bovine rotavirus vaccine reassortant (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors Serum Institute of India
- 13 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 05 Jan 2011 New trial record